ResearcherFujian Medical UniversityNo recent work listed
Xuenong Ouyang
Matched on OpenAlex author ID A5103516893. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 0, last author 6)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 14
2012: 1 paper · 2013: 1 paper · 2014: none · 2015: none · 2016: 2 papers · 2017: 2 papers · 2018: 1 paper
Papers 7
- BTG1 low expression in pancreatic ductal adenocarcinoma is associated with a poorer prognosis. Last author DOI 10.5301/ijbm.5000310↗
- Clinicopathologic features and prognostic implications of MYBL2 protein expression in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.prp.2017.04.024↗
- Expression and clinical significance of placenta-specific 1 in pancreatic ductal adenocarcinoma. Last author DOI 10.1177/1010428317699131↗
- Expression and prognosis value of SHP2 in patients with pancreatic ductal adenocarcinoma. Last author DOI 10.1007/s13277-015-4675-5↗
- Impact of S100A4 Expression on Clinicopathological Characteristics and Prognosis in Pancreatic Cancer: A Meta-Analysis. Last author DOI 10.1155/2016/8137378↗
- CacyBP/SIP enhances multidrug resistance of pancreatic cancer cells by regulation of P-gp and Bcl-2. Last author DOI 10.1007/s10495-013-0831-9↗
- Overexpression of CIAPIN1 inhibited pancreatic cancer cell proliferation and was associated with good prognosis in pancreatic cancer. Last author DOI 10.1038/cgt.2012.28↗
Closest collaborators
The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Xiong Chen · 4 shared papers, 2016–2018 · strength 0.26
- Paper BTG1 low expression in pancreatic ductal adenocarcinoma is associated with a poorer prognosis. DOI 10.5301/ijbm.5000310↗
- Paper Expression and clinical significance of placenta-specific 1 in pancreatic ductal adenocarcinoma. DOI 10.1177/1010428317699131↗
- Paper Expression and prognosis value of SHP2 in patients with pancreatic ductal adenocarcinoma. DOI 10.1007/s13277-015-4675-5↗
- Jiawei Zheng · 4 shared papers, 2016–2018 · strength 0.26
- Paper BTG1 low expression in pancreatic ductal adenocarcinoma is associated with a poorer prognosis. DOI 10.5301/ijbm.5000310↗
- Paper Expression and clinical significance of placenta-specific 1 in pancreatic ductal adenocarcinoma. DOI 10.1177/1010428317699131↗
- Paper Expression and prognosis value of SHP2 in patients with pancreatic ductal adenocarcinoma. DOI 10.1007/s13277-015-4675-5↗
- Shanshan Huang · 3 shared papers, 2016–2018 · strength 0.20
- Paper BTG1 low expression in pancreatic ductal adenocarcinoma is associated with a poorer prognosis. DOI 10.5301/ijbm.5000310↗
- Paper Expression and clinical significance of placenta-specific 1 in pancreatic ductal adenocarcinoma. DOI 10.1177/1010428317699131↗
- Paper Expression and prognosis value of SHP2 in patients with pancreatic ductal adenocarcinoma. DOI 10.1007/s13277-015-4675-5↗
- Yu-Fang Huang · 3 shared papers, 2016–2018 · strength 0.20
- Paper BTG1 low expression in pancreatic ductal adenocarcinoma is associated with a poorer prognosis. DOI 10.5301/ijbm.5000310↗
- Paper Expression and prognosis value of SHP2 in patients with pancreatic ductal adenocarcinoma. DOI 10.1007/s13277-015-4675-5↗
- Paper Impact of S100A4 Expression on Clinicopathological Characteristics and Prognosis in Pancreatic Cancer: A Meta-Analysis. DOI 10.1155/2016/8137378↗
- Yin Yin · 3 shared papers, 2016–2017 · strength 0.19
- Paper Expression and clinical significance of placenta-specific 1 in pancreatic ductal adenocarcinoma. DOI 10.1177/1010428317699131↗
- Paper Expression and prognosis value of SHP2 in patients with pancreatic ductal adenocarcinoma. DOI 10.1007/s13277-015-4675-5↗
- Paper Impact of S100A4 Expression on Clinicopathological Characteristics and Prognosis in Pancreatic Cancer: A Meta-Analysis. DOI 10.1155/2016/8137378↗
- Yan Zhang · 2 shared papers, 2017 · strength 0.13
- Jie Li · 2 shared papers, 2013–2017 · strength 0.10
- Ranjie Yu · 1 shared paper, 2017 · strength 0.06
- Qun Chen · 1 shared paper, 2017 · strength 0.06
- Xiong Chen · 1 shared paper, 2017 · strength 0.06
- Song Li · 1 shared paper, 2016 · strength 0.06
- Shanshan Huang · 1 shared paper, 2016 · strength 0.06
- X Chen · 1 shared paper, 2012 · strength 0.04
- Xiong Chen · 1 shared paper, 2013 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.